Details of the Drug

General Information of Drug (ID: DM5ICUT)

Drug Name

BJ-001

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Recombinant protein

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04294576) Safety Study of BJ-001, and IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors (FIH). U.S. National Institutes of Health.